Crizalk 250 mg Capsule
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Crizalk 250 mg Capsule

Crizalk 250 mg Capsule

Crizalk 250 mg Capsule contains crizotinib, a targeted anticancer medicine used for certain types of non-small cell lung cancer. It works by blocking abnormal ALK and ROS1 signaling pathways that can promote cancer cell growth. The capsule is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Category

Crizalk 250 mg Capsule contains 250 mg of crizotinib and is formulated as a hard gelatin capsule for oral administration. It is indicated for patients with locally advanced or metastatic non-small cell lung cancer whose tumors have specific ALK or ROS1 alterations. The capsule can be taken with or without food and should be swallowed whole with water. Treatment should be prescribed and monitored by an experienced oncology specialist.

Technical Specification

Specification Details
Active Ingredient Crizotinib 250 mg
Dosage Form Hard Gelatin Capsule
Therapeutic Class Tyrosine Kinase Inhibitor
Main Indication Non-Small Cell Lung Cancer
Molecular Targets ALK and ROS1
Route of Administration Oral

Product Also Known As

Crizalk 250 mg Capsule, Crizalk Crizotinib 250 mg Capsule, Crizotinib 250 mg Capsule, Crizotinib Hard Capsule, Crizotinib Lung Cancer Capsule, Crizotinib ALK Inhibitor Capsule